NL-OMON35117已完成不适用
Obesity treatment and changes in glucose tolerance: the role of physical activity and sleep - Obesity treatment and glucose tolerance
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Subject must be enrolled or in the intake procedure of the CO-EUR treatment programme
- •minimum 18 years of age
- •BMI > 30 kg/m2
- •The inclusioncriteria of the CO-EUR treatment center are also minimum 18 years of age and a BMI > 30kg/m2
排除标准
- •insulin dependent diabetics are excluded
研究者
相似试验
已完成
不适用
Study on glycemic control, weight, body fat and insulin resistance in SGLT2 inhibitor-treated Japanese patientsType 2 diabetesJPRN-UMIN000016635Medical Corporation H.E.C Science Clinic30
已完成
不适用
A study in subjects with impaired glucose tolerance (IGT) to evaluate effects of AO-128 on prevention of type 2 diabetes mellitus (Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison)Impaired glucose tolerance (IGT)JPRN-UMIN000001109Takeda Pharmaceutical Company Limited1,782
已完成
不适用
Effects for glucose metabolism, body composition, and circulatory dynamics of SGLT2 inhibitorType 2 diabetes mellitusJPRN-UMIN000017195Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki30
已完成
2 期
Study of the glucose metabolism-improving effect of the 12-week intake of beverages containing lactic acid bacteriaHyperglycemiaJPRN-UMIN000023466HUMA R&D CORP130
已完成
2 期
Study of the glucose metabolism-improving effect of the 12-week intake of food containing lactic acid bacteria: A randomized, double-blind, placebo-controlled, parallel-group studyHyperglycemiaJPRN-UMIN000032837KSO Corporation130